Unlearn is a series a startup based in United States. 1 investor tracked.
Based in the United States, Unlearn is a startup founded in 2018. Brouky records 3 investors associated with the company.
Unlearn develops AI-driven digital twin models and evidence-based modeling tools for clinical development, providing software to plan, monitor, and analyze clinical trials to improve decision-making and reduce uncertainty in drug development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.